ACTA1 and Hepatic fibrosis: Furthermore, treatment with AAV-shGli1 significantly reduced liver fibrosis in Mdr2-/- mice, as assessed by inflammatory cell infiltration (H&E staining), collagen (SR staining and the percentage of SR+ area), and α-SMA expression (Figure 6D-E).